相关实验视频

Updated: May 27, 2025

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

对于神经内分泌瘤的放射性药物的前沿

Ameya D Puranik¹, Indraja D Dev², Vikas Prasad³

¹Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.

Journal of neuroendocrinology

|February 17, 2025

概括

神经内分泌瘤 (NETs) 越来越多地被诊断出来,这凸显了对先进成像学的需要. 本综述探讨了用于NET诊断和管理的当前和未来放射性药物.

科学领域:

在瘤学瘤学.
核医学就是核医学.
放射性药理学是一种放射性药理学.

背景情况:

神经内分泌瘤 (NETs) 起源于神经细胞,曾经被认为是罕见的.
改进的诊断和理解导致了NET发病率和检测率的显著上升.
在NET中瘤异质性需要先进的成像技术,如双追踪器 (例如FDG PET/CT) 成像.

研究的目的:

审查用于神经内分泌瘤 (NET) 成像的现有和新兴放射性药物.
讨论这些放射性药物对NET的诊断算法和管理策略的影响.
解决目前用于NET患者疾病评估和预后的成像生物标志物的局限性.

主要方法:

对用于神经内分泌瘤诊断中的放射性药物当前文献的综述.
探索新兴趋势和新型放射性药物载体的索马托他因子受体向.
分析成像在NET患者管理决策中的作用.

主要成果:

越来越多的NET导致了先进的成像模式的采用.
目前的成像生物标志物可能不足以对NET患者的一个子集进行全面的疾病评估.
目前还需要探索替代途径和改进的载体,以向索马托斯塔丁受体.

结论:

放射性药物在神经内分泌瘤的不断发展的诊断和管理环境中起着至关重要的作用.
放射性药物的未来进展预计将对NET的临床实践产生重大影响.
进一步研究新型放射性追踪剂和向策略对于改善NET患者的治疗结果至关重要.

关键词:

卢177-77 这是一本书.在这里,PET是PET.这是一个很大的问题.PRRT PRRT 索马托斯塔丁受体索马托斯塔丁受体神经内分泌瘤是一个神经内分泌瘤.

更多相关视频

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...